Enanta PharmaceuticalsENTA 
$11.66-1.27%24h
-1.27%24h
Global rank16028
Market cap$244.50M
Change 7d-5.59%
YTD Performance25.11%
SP500 benchmarkOutperform
P/E-1.83
P/S3.09
Revenue$79.20M
Earnings-$133.82M
Dividend yield-
Main Sector
Healthcare
Category
Enanta Pharmaceuticals (ENTA) Total Liabilities
ENTA Total Liabilities in 2022: $245.54M
According to Enanta Pharmaceuticals latest financial reports the total liabilities of ENTA is $245.54M, an increase of 354.06% to 2022. At the end of 2022 company had $54.08M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Enanta Pharmaceuticals is responsible for during its operational activities.
Enanta Pharmaceuticals (ENTA) Total Liabilities History from 2023 to 2022
-
Value:-
ENTA Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $245.54M | 354.06% |
| 2022 | $54.08M | 37.38% |
| 2021 | $39.36M | 28.84% |
| 2020 | $30.55M | 11.76% |
| 2019 | $27.34M | 217.06% |
| 2018 | $8.62M | - |
View the Top Total Liabilies Stocks
